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ABSTRACT
GW bodies (or P-bodies) are cytoplasmic granules
containing proteins involved in both mRNA degra-
dation and storage, including the RNA interference
machinery. Their mechanism of assembly and
function are still poorly known although their
number depends upon the flux of mRNA to be
stored or degraded. We show here that silencing of
the translational regulator CPEB1 leads to their
disappearance, as reported for other GW body
components. Surprisingly, the same results were
obtained with several siRNAs targeting genes
encoding proteins unrelated to mRNA metabolism.
The disappearance of GW bodies did not correlate
with the silencing activity of the siRNA and did not
inhibit further silencing by siRNA. Importantly, in
most cases, GW bodies were rapidly reinduced by
arsenite, indicating that their assembly was not
prevented by the inhibition of the targeted or
off-target genes. We therefore propose that some
siRNA sequences affect mRNA metabolism so as to
diminish the amount of mRNA directed to the GW
bodies. As an exception, GW bodies were not
reinduced following Rck/p54 depletion by interfer-
ence, indicating that this component is truly
required for the GW body assembly. Noteworthy,
Rck/p54 was dispensable for the assembly of stress
granules, in spite of their close relationship with the
GW bodies.
INTRODUCTION
GW bodies, also called dcp bodies, or P-bodies in yeast,
are recently described cytoplasmic structures involved in
mRNA metabolism. They were ﬁrst implicated in mRNA
degradation. In eukaryotes, mRNA degradation is
initiated by the removal of the polyA tail followed by
either 3’ to 5’ degradation by the exosome or decapping of
the 5’ extremity and 5’ to 3’ degradation by Xrn1. GW
bodies contain all the proteins of the 5’ to 3’ mRNA
degradation machinery, including the decapping complex
Dcp1/2, its cofactors LSm1-7 and Rck/p54 (also known as
Dhh1 in yeast, Me31 in drosophila and Cgh1 in
Caenorhabditis) and the exonuclease Xrn1 (1). In yeast,
experiments designed to slow down the ﬁnal steps of
mRNA degradation enhance P-bodies in size and number.
This has been observed following mutations of Dcp1 or
Xrn1 (2). Moreover, when a poly(G) tract is introduced
into a reporter mRNA to block exonucleolysis, it
accumulates in P-bodies, indicating that they are active
sites of mRNA degradation (2). Similarly, in mammals,
polyadenylated RNA are detected in GW bodies following
the stable depletion of Xrn1 by RNA interference (3).
Furthermore, inhibiting translation with a drug which
releases free mRNA, such as puromycin, leads to an
increase of the GW body number (4). Conversely, when
mRNAs are frozen on polysomes by a translation
inhibitor such as cycloheximide, GW bodies disappear
(2,3). Taken together, these data indicate that GW bodies
are formed from a pool of untranslated mRNAs available
for degradation.
GW bodies also contain the post-transcriptional gene
silencing machinery, including both proteins of the RNA-
induced silencing complex (RISC), such as Argonaute
(Ago), and short RNAs, whether short interfering RNAs
(siRNAs) or micro-RNAs (miRNAs) (5–8). One of the
GW body markers, GW182, which was initially identiﬁed
as a human autoantigen, turned out to be a direct Ago
partner (5). These observations have led to the proposal
that GW bodies are the sites of RNA interference activity.
This issue is controversial, as some studies report the
inhibition of both mi-RNA- and si-RNA-mediated inter-
ference in the absence of GW bodies (8), while others
report a clear inhibition of mi-RNA-mediated interference
and a slight inhibition of si-RNA-mediated interference
(5,9); a few even indicate no inhibition of the si-RNA-
mediated interference (10,11). The presence of RISC in the
GW bodies is consistent with the need to degrade the
fragments generated by the initial siRNA-mediated
mRNA cleavage (12). At ﬁrst glance, the presence of
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inhibition and not mRNA cleavage. Recently, it has
become clear that miRNA-mediated silencing can result in
RNA decay, initiated by deadenylation and decapping
rather than endonucleolytic cleavage (1). In addition, GW
bodies can also play a role in mRNA storage. In Huh7
hepatoma cells, the CAT1 mRNA is repressed by miR122
and localized in GW bodies. Following amino acid
deprivation, its translation resumes and it disappears
from the GW bodies (13).
A more general role for GW bodies in mRNA storage is
still uncertain in mammals but has been established for
P-bodies in yeast. When glucose deprivation leads
to translation arrest and accumulation of mRNAs in
P-bodies, glucose re-addition leads to mRNAs leaving
the P-bodies and resuming translation (14). Therefore,
P-bodies have a dual role in mRNA degradation and
storage, albeit it is still unclear how these two opposite
functions are coordinated. In addition, mammalian cells
harbor distinct cytoplasmic structures involved in mRNA
storage, the stress granules, which are induced by stress.
They contain their own set of proteins, including
translation initiation factors, such as eIF3, and translation
repressors, such as TIA1/TIAR, as well as some of the
GW body proteins, such as Xrn1 (15). Stress granules are
frequently in contact with GW bodies. In some cases, they
recruit GW bodies and seem to fuse with them. We have
proposed that this intermingling between stress granules
and GW bodies could trigger the transition from mRNA
storage to mRNA degradation during stress (4).
The number of GW bodies per cell is variable, even
within a clonal cell population. How this number could
impact on their presumed function is unknown. First, it is
unclear whether a GW body needs to be macroscopic in
order to fulﬁll its function. Second, the GW body
assembly pathway is still unknown. One of the reported
parameters is the position of the cells in the cell cycle.
Most GW bodies disappear before mitosis, reassemble in
the G1 phase and enlarge in late S and G2 phases (16).
It has been proposed, as a consequence, that the eﬃciency
of RNA interference may vary during the cell cycle (17).
In addition, several proteins of the GW bodies have been
reported to be essential for the GW body assembly,
because their depletion by RNA interference leads to the
disappearance of GW bodies. This has been observed for
Ccr4, Rck/p54, Lsm1 and eIF4ET (18); GW182 (16), Ge1
(19) and Rap55 (20). One interpretation of this data is that
some of these proteins have a scaﬀolding role in GW body
assembly. Alternatively, all of them may be necessary to
ensure a certain level of repressed mRNA required for the
GW body assembly (1).
We have previously shown that the translational
regulator CPEB1 is enriched in GW bodies. This raised
the possibility that it could play an active role in the
degradation of the mRNA to which it is bound.
Alternatively, it could be passively attracted by its target
mRNA as a consequence of the translation repression (4).
While investigating CPEB1 function using RNA inter-
ference, we found that siRNAs targeting CPEB1 also led
to GW body disassembly. Surprisingly, this property was
shared with several other siRNAs and appeared to be
independent of the gene targeted. The siRNA-guided
RNA interference had the same eﬃciency in the absence of
GW bodies, demonstrating that these bodies were not the
sites of action of the RISC machinery. Finally, except in
the case of si-p54, arsenite could counteract the eﬀect of
these siRNAs, despite the fact that this drug prevents
protein synthesis, thus conﬁrming that CPEB1 protein is
not involved in GW body assembly whereas p54 is truly
required.
MATERIALS AND METHODS
Cell culture
Epithelioid carcinoma HeLa cells and retinal pigment
epithelial RPE-1 cells (BD Biosciences Clontech, France)
were routinely maintained in DMEM and DMEM/F12,
respectively, supplemented with 10% fetal calf serum.
IFN-a2b was a kind gift of Pierre Eid (Institut Andre ´
Lwoﬀ, Villejuif, France). For stress induction, cells were
treated with 0.5mM arsenite (Sigma Aldrich, France)
for 30min.
Transfections were performed with 3mg si-RNA or
polyI/C per 35-mm diameter dish using a standard
calcium phosphate procedure, as described previously
(4). siRNAs and polyI/C were purchased from MWG
(MWG Biotech, France) and Sigma (Sigma Aldrich,
France), respectively. The siRNA concentration was
checked both by spectrophotometry and on gel (data not
shown). In Figure 1, control cells were transfected with
1.3mg of a human CPEB1-long expression vector
(IMAGE 6047179). Si-Eg5 was transfected as previously
described (21).
IFN dosage was performed as previously described (22).
Each sample was tested in duplicate and the dosage was
repeated twice. Brieﬂy, UPIL reporter cells were plated in
100ml in a 96-well plate and cultured overnight following
the addition of 25ml of each culture medium sampled from
siRNA-transfected cells. The standard curve was obtained
by culturing the cells in the presence of serial dilutions of
IFN-a2at 100 000units/ml. Luciferase activity was then
measured using a Steady-Glo luciferase assay system
(Promega, France).
Antibodies
Monoclonal anti-CPEB1 and anti-Kif15 antibodies were
raised in our laboratory (4,23). Rabbit polyclonal anti-p54
and mouse monoclonal DM1 anti-a-tubulin were pur-
chased from Bethyl Laboratories Inc. (Texas, USA) and
Sigma Aldrich (France), respectively. The anti-GW182
human index serum was a kind gift from Theophany
Eystathoy (University of Calgary, Alberta, Canada), the
anti-hDcp1 rabbit antibody from Bertrand Se ´ raphin
(Centre de Ge ´ ne ´ tique Mole ´ culaire, Gif, France) and the
anti-eIF3 goat antibody from John Hershey (University of
California, Davis, CA). Secondary antibodies conjugated
to rhodamine, FITC and horseradish peroxidase were
purchased from Jackson Immunoresearch Laboratories
(Immunotech, France). Monoclonal TS9 anti-CD9 and
TS81 anti-CD81 antibodies (24) were obtained from
Diaclone (Besanc ¸ on, France).
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Figure 1. CPEB1 silencing leads to the disappearance of GW bodies. (A) Silencing of CPEB1. HeLa cells were transfected with indicated siRNAs.
After 44h, proteins were extracted and 50mg of this was analyzed by western blot with anti-CPEB1 antibody. Ten micrograms of proteins from
HeLa cells transfected with a human CPEB1-long expression vector were used as a size control. Note that the antibody recognizes a non-CPEB1
protein (
) that attests an equal protein loading. The migration of molecular weight markers is indicated on the right. (B–E) Disappearance of GW
bodies following si-CPEB1 transfection. HeLa (B– D) or RPE (E) cells were transfected with indicated siRNAs. Mock is a control transfection with
siRNA buﬀer alone. After 44h (B, C, E) or 72h (D), cells were ﬁxed and stained with anti-Dcp1 (B, D) or anti-GW182 (C) antibodies and observed
by ﬂuorescence microscopy. For (B) and (E), nuclei were stained with DAPI (blue). (F) Quantiﬁcation of the disappearance of GW bodies.
The number of GW bodies per cell, counted in 100 cells, is presented for the experiments illustrated in (B–E). (G) Cell cycle analysis. HeLa and RPE
cells were transfected with si-Glo.1 (red) or si-CPEB1.1 (black) and cell cycle was analyzed by cytoﬂuorimetry 48h later.
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Cells were scraped in PBS, resuspended in a lysis buﬀer
(50mM Tris-HCl pH8, 150mM NaCl, 1mM EDTA, 1%
Nonidet P-40) supplemented with Complete Protease
Inhibitor cocktail (Roche Diagnostics, France) and incu-
bated on ice for 30min. Soluble proteins were recovered
after centrifugation at 15000g and 48C for 10min and
quantitated by the Bradford method (Bio-Rad, France).
Proteins were separated on a 7.5% polyacrylamide
SDS-PAGE gel along with the Prestained Protein Ladder
10–180kDa (MBI Fermentas, France) and transferred to a
nitrocellulose Hybond-C-Extra membrane (Amersham
Pharmacia, France). All incubations were then performed
at room temperature. Non-speciﬁc protein-binding sites
were blocked by incubation in PBS-T (PBS, 0.1%
Tween-20) containing 5% (wt:vol) non-fat dry milk for
1h. The membrane was successively incubated with
primary antibody diluted in PBS-T containing 5% non-
fat dry milk for 1h, washed in PBS-T, incubated with
horseradish-peroxidase-conjugated secondary antibody
for 45min and washed in PBS-T. Immune complexes
were detected using the SuperSignal Chemiluminescent
Substrate detection reagent (Perbio Science, France), and
quantiﬁed by densitometry of the X-Ray ﬁlm. The
membrane was dehybridized for 30min by incubation in
50mM Tris-HCl pH 6.7, 10mM b-mercaptoethanol, 0.5%
SDS at 528C before a second hybridization.
Immunofluorescence
Cells were grown on glass coverslips and ﬁxed in 208C
methanol for 3min. Cells were incubated with the primary
antibody for 1h, rinsed with phosphate buﬀered saline
(PBS), incubated with the secondary antibody for 30min,
rinsed with PBS and stained with 0.12mg/ml DAPI for
1min, all steps being performed at room temperature.
Slides were mounted in Citiﬂuor (Citiﬂuor, UK) and
observed on a Leica DMR microscope (Leica, Heidelberg,
Germany) using a 63X1.32 oil immersion objective.
Photographs were taken using a Micromax CCD camera
(Princeton Instruments).
Flow Cytometry
For the quantiﬁcation of CD9 and CD81 expression, each
cell sample was divided in two. All steps were then
performed on ice. Cells were rinsed twice in PBS contain-
ing 0.1% BSA and incubated in the presence or absence of
the corresponding primary antibody for 20min. Cells were
rinsed twice in PBS 0.1% BSA and incubated in the
presence of TRITC-conjugated anti-mouse antibodies for
20min. After rinsing three times, samples were analyzed
with a FACSscan (Becton Dickinson, USA) and popula-
tions were deﬁned using the WinMDI software.
The percentage of silencing was calculated using the
position of the ﬂuorescence peak in silenced cells with
respect to unsilenced ones.
Cell cycle analysis following si-Eg5 transfection was
performed after propidium iodide staining of the DNA.
After precipitation overnight in 70% ethanol at 208C,
cells were resuspended in PBS containing 50mg/ml
propidium iodide and 20mg/ml RNase A and incubated
at 378C for 30min. Samples were analyzed with a
FACSscan (Becton Dickinson, USA) and cell cycle
partition was calculated using the WinMDI software.
RT-PCR
Total RNA was extracted using the SV Total RNA
Isolation kit (Promega, France) and quantiﬁed by spectro-
photometry. Reverse transcription reactions were
performed with 1mg RNA using random primers and
Mu-MLV reverse transcriptase (Invitrogen, France). One-
tenth of the reaction was used for PCR ampliﬁcation with
OAS2primers[(GCTTTGATGTGCTTCCTGCCTT) and
(ACCCCTTTGGCTTCAGTTTCCTT)], which ampliﬁed
a 249-bp product or b-actin primers [(AGAG
CTACGAGCTGCCTGAC) and (AGTACTTGCGCTC
AGGAGGA)], which ampliﬁed a 300- bp product. PCR
conditions were 35 cycles (948C for 45s, 608C for 60 s and
728Cfor45s)and17 cycles (948Cfor30s,558Cfor30 sand
728C for 30s) for OAS2 and b-actin, respectively. The
ampliﬁcation products were separated on a 1.2% agarose
gel, stained with ethidium bromide and quantiﬁed using a
Fluor-S-Max imaging system (Bio-Rad, France). Each
primer set targeted two separate exons in order to
distinguish reverse transcribed mRNAs from residual
genomic DNA.
RESULTS
Silencing of CPEB1 leads to the disappearance of
GW bodies
We have previously shown the presence of the transla-
tional inhibitor CPEB1 in GW bodies. In order to gain
insight into its function at that location, we used RNA
interference to repress endogeneous CPEB1. HeLa cells
were transfected with two siRNAs directed against human
CPEB1 (si-CPEB1.1 and si-CPEB1.2), and the eﬃciency
of the depletion was checked after 44h by western blot
using 4A2 monoclonal anti-CPEB1 antibody (Figure 1A).
Because this antibody detects two bands in the 50–70kD
region, cells transfected with a human CPEB1 expression
vector were used as a control of CPEB1 migration.
A siRNA targeting rabbit beta-globin (si-Glo.1) was used
as an irrelevant siRNA. Both si-CPEB1s led to the
disappearance of endogeneous CPEB1 protein. In a
parallel culture dish, cells were ﬁxed and GW bodies
were immunostained with anti-Dcp1 antibodies. The
number of GW bodies was reduced after si-CPEB1.1
and si-CPEB1.2 transfection, compared to mock or
si-Glo.1 transfected cells (Figure1B). The same result
was obtained using an antibody directed against GW182
as a second marker of the GW bodies (Figure 1C). This
eﬀect persisted 72h after transfection (Figure 1D). We
repeated the experiment in a second human cell line, RPE,
and observed a similar eﬀect (Figure 1E). The phenom-
enon was quantiﬁed by measuring the distribution of GW
bodies per cell (Figure 1F). Compared to si-Glo.1,
si-CPEB1.1 led to a similar decrease in HeLa and RPE
cells, which intensiﬁed between 44 and 72h. The eﬀect was
general rather than concerning a subpopulation of cells.
4718 Nucleic Acids Research, 2007, Vol. 35, No. 14Because several targets of the CPEB1 regulatory
pathway play a role in cell division during early
development (Cyclin B1, Histone H3, kinesin Eg5, etc.)
the depletion of CPEB1 protein could have an impact on
cell proliferation. As the GW body number was reported
to vary during the cell cycle, HeLa and RPE cells were
transfected with si-CPEB1.1 or si-Glo.1 and stained 44h
later with propidium iodide in order to analyze the cell
cycle by cytoﬂuorimetry (Figure 1G). No diﬀerence
was observed, indicating that the disappearance of GW
bodies was not due to the disturbance of the cell cycle
by CPEB1 repression. Taken together, these observa-
tions suggested that CPEB1 is required for GW body
maintenance.
The disappearance of GWbodies is inducedby avariety
of siRNAs
Regulation by CPEB1 is only one among several transla-
tion regulation pathways. CPEB1 is an mRNA-binding
protein known to be involved in the mRNA storage of a
subset of speciﬁc mRNAs and, so far, not in mRNA
degradation. It was therefore surprising that it could play
a general role in GW body assembly. In order to clarify
the signiﬁcance of our observation, we tested two other
siRNAs targeting CPEB1 and a set of 10 additional
siRNAs targeting mRNA encoding proteins of various
functions: (i) Rck/p54 DEAD-box helicase, which is a
CPEB1 partner localizing to the GW bodies, (ii) the
kinesin Kif15 and the kinesin-related protein HSET as
examples of cytoplasmic proteins absent from GW bodies,
(iii) the tetraspanins CD9 and CD81 as examples of
transmembrane proteins and (iv) the rabbit b-Globin and
the mouse Lymphotoxin-a (LT-a) as irrelevant controls,
since the orthologous genes are not expressed in these
cells. As a non-siRNA control, we also tested poly I/C,
which is a double-stranded homopolymer of RNA
supplied as a mixture of 100–600-bp-long molecules
(data not shown).
HeLa cells and RPE cells were transfected with equal
amounts of these siRNAs and analyzed 48h later. The
pattern was identical in the two cell lines, with the number
of GW bodies being either similar to what is seen in
untransfected cells, or strongly decreased, depending on
the siRNA. Si-CPEB1.3 and si-CPEB1.4 had little eﬀect
whereas si-p54 led to the complete disappearance of the
GW bodies, as previously described (18) (Figure 2A).
PolyI/C partially decreased the number of GW bodies
(Figure 2B). In addition, one of the three siRNAs
targeting CD81, si-CD81.2, and one of the irrelevant
siRNAs, si-Glo.2, led to the disappearance of GW bodies
(Figure 2C and D). Taken together, poly I/C showed an
intermediate eﬀect, while 5 of the 15 siRNAs tested led to
a strong diminution of the GW bodies, with no obvious
link with the function of their expected target: si-CPEB1.1,
si-CPEB1.2, si-p54, si-Glo.2 and si-CD81.2.
siRNA effecton GW bodiesdoes notdepend on their
interference activity
Because some siRNAs are more potent in RNA
interference than others, we investigated whether the
eﬀect on GW bodies correlated with the eﬃciency of
silencing. In fact, si-CPEB1.1 and si-CPEB1.2 are active
both in decreasing the GW body number and in depleting
CPEB1 (Figure 1A), whereas si-CPEB1.3 and si-CPEB1.4
are inactive on both (Figures 2A and 3A). We therefore
systematically measured the activity of the siRNAs,
except for the irrelevant b-globin and LT-a siRNAs,
which have no predictable mRNA targets expressed in
HeLa or RPE cells.
The activity of si-Kif15 and si-p54 was measured by
western blot 44h after transfection (Figure 3A). Both
siRNAs had similar silencing activity, whereas only si-p54
led to the disappearance of GW bodies. The activity of the
siRNA targeting the tetraspanins was measured by
cytoﬂuorimetry using antibodies directed against CD9
and CD81 (Figure 3B). The four siRNAs were active on
their respective targets, with 70% silencing eﬃciency for
si-CD9 and 84–95% eﬃciency for CD81 siRNAs.
Strikingly, the only siRNA which led to the disappearance
of GW bodies, si-CD81.2, had the same silencing activity
as the two other si-CD81s. This data is summarized in
Table 1. There is clearly no correlation between the
silencing activity of the siRNAs and their eﬀect on the
GW body number.
siRNA effect on GWbodies does notinvolve theinterferon
pathway
Having found that the eﬀect of siRNAs on the GW bodies
is related to their sequence, as not all of them decrease the
GW body number, but neither to their expected target nor
to their interference activity, as illustrated by the three
si-CD81s, we hypothesized that they could activate a
pathway distinct from the silencing machinery. Although
siRNAs are short double-stranded RNA molecules 21nt
long, it has been reported that some of them do activate
the interferon (IFN) pathway in certain cell lines in a
sequence-dependent manner (25,26). We therefore con-
sidered this pathway as a candidate mechanism for the
reduction of GW body number.
We ﬁrst investigated whether IFN was produced in
response to the transfection of the various siRNAs. RPE
cells were transfected as described previously and the
culture medium was sampled 48h later. The presence of
IFN was assayed using the UPIL5 reporter cell line which
expresses luciferase under the control of an IFN respon-
sive promoter (22). Despite the sensitivity of this assay, no
IFN could be detected, indicating that its production, if
any, is less than 50units per ml (Figure 4A). In parallel,
we analyzed the expression of OAS2 which has been
shown to be one of the IFN-responsive genes that is the
most induced by siRNAs (15-fold at 48h in RCC1 cells, as
reported in Sledz et al. (27)). RNA was extracted and the
OAS2 expression was analyzed by RT-PCR along with a
b-actin control. Overall, siRNA transfection rather led to
a slight decrease of OAS2 expression with respect to
b-actin (Figure 4B), including si-CPEB1.2 and si-Glo.2
and both of these decrease the GW body number. This
suggested that the IFN pathway is not induced in these
transfection conditions.
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GW bodies. HeLa cells were cultured in the presence of
10
3u/ml IFN-a for up to 48h and GW bodies were
analyzed by immunoﬂuorescence. At this time, the IFN
treatment had no eﬀect on the GW body number (data not
shown). The full activation of the IFN pathway involves
the presence of double-stranded RNA which, in our
siRNA transfection experiments, could be provided by
the siRNA itself. We used polyI/C as a conventional
co-activator of the IFN response. Cells were cultured in the
presence of 10
3u/ml IFN-a for 40h and then transfected
with polyI/C in the presence of IFN-a. GW bodies were
analyzed by immunoﬂuorescence 8h later, at a time where
polyI/C transfection alone does not aﬀect the GW body
number. Even under these conditions, IFN had no eﬀect
on GW bodies (data not shown). In conclusion, we ﬁnd no
si-CPEB1.3 mock
si-CPEB1.4 si-p54
A si-HSET Si-Kif15
Poly I/C mock
B
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D
Figure 2. Various siRNAs lead to the disappearance of GW bodies. HeLa and RPE cells were transfected with indicated siRNAs. Cells were ﬁxed
after 48h, stained with anti-Dcp1 antibodies and observed by ﬂuorescence microscopy. Representative photographs from either HeLa (A) or RPE
(B–D) cells are presented.
4720 Nucleic Acids Research, 2007, Vol. 35, No. 14evidence for an involvement of the IFN pathway in
the disappearance of GW bodies following siRNA
transfection.
The disappearance of GWbodies does notaffectRNA
interference
The silencing machinery accumulates in GW bodies,
including proteins of the RISC complex and siRNAs.
Some of the GW body components are then required for
the degradation of the cleaved RNA products. We
therefore investigated whether the disappearance of GW
bodies decreases the eﬃciency of RNA interference by
siRNAs.
We ﬁrst used si-Eg5 as a reporter of siRNA activity.
The Eg5 kinesin is required for mitosis and its depletion
leads to a phenotype of prometaphase arrest which can be
quantiﬁed, as previously described (21). HeLa cells were
mock transfected, transfected with si-Glo.1 or si-LT.1,
which do not change the number of GW bodies, or
transfected with si-Glo.2, si-CPEB1.1 or si-p54, which
do decrease their number. After 40h, cells were divided
in two and transfected 8h later with either buﬀer
alone or si-Eg5. The cell cycle was analyzed 40h later
by cytoﬂuorimetry after propidium iodide staining
(Figure 5A). A G2/M blockage of about 60% was
observed in all cultures, indicating that the si-Eg5
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Nucleic Acids Research, 2007, Vol. 35, No. 14 4721is as eﬃcient in the absence as in the presence of GW
bodies.
In case this phenotype was dependent on an Eg5 protein
threshold and therefore not sensitive to small variations in
silencing eﬃciencies, we performed a similar experiment in
RPE cells using si-Kif15 as a reporter of siRNA activity
and testing its eﬃciency directly by western blot analysis.
RPE cells were mock transfected, transfected with
si-Glo.1, which does not change the number of GW
bodies, or transfected with si-Glo.2, si-p54 or si-CPEB1.1,
which do decrease their number. After 24h, cells were
divided in two and transfected 7h later with buﬀer alone
or si-Kif15. Proteins were analyzed 24h later by western
blot (Figure 5B). At this time, Kif15 depletion was
incomplete and similar in all samples, conﬁrming that
the silencing eﬃciency does not depend on the presence of
GW bodies.
Similar experiments were previously reported using a
siRNA targeting GW182 to decrease the GW body
number, and subsequently testing interference of lamin
A/C (8). The authors observed a strong inhibition of lamin
silencing, suggesting the requirement of either intact GW
bodies or GW182 for an eﬃcient interference (8).
To enable the comparison with these results, we investi-
gated the eﬀect of the same si-GW182 on Eg5 and Kif15
silencing. Despite a clear reduction of GW bodies
(Figure 5C), we did not observe any signiﬁcant inhibition
of further silencing (Figure 5D and E). Neither did
si-GW182 or si-p54 have any signiﬁcant eﬀect on the
subsequent silencing of lamin A/C (Figure 5F), conﬁrming
that si-RNA-driven interference does not require intact
GW bodies.
Table 1. Silencing eﬃciency of the siRNAs and GW body number
siRNA Sequence Silencing
eﬃciency
GW
body
number
si-CPEB1.1 CACCUUCCGUGUUUUUGGCUCTT + 
si-CPEB1.2 CUCUCAGAUUUGAUUUCAATT + 
si-CPEB1.3 GAAGGUUCAGAUUGACCCCTT  +
si-CPEB1.4 CACCCUCAGUUAGAGGAUCTT  +
si-p54 CCAAAGGAUCUAAGAAUCATT + 
si-Kif15 GCACAACUCCUGCAAAUUCTT + +
si-HSET CCAGCAGCTTCAGGACCAATT + +
si-CD81.1 GCCCAACACCUUCUAUGUATT + +
si-CD81.2 CACGUCGCCUUCAACUGUATT + 
si-CD81.3 GCACCAAGUGCAUCAAGUATT + +
si-CD9 GAGCAUCUUCGAGCAAGAATT + +
si-Glo.1 GGUGAAUGUGGAAGAAGUUTT n.a.
 +
si-Glo.2 GGCUCAUGGCAAGAAGGUGTT n.a.
 
si-LT.1 GCAGAACUCACUGCUCUGGUU n.a.
 +
si-LT.2 UAACCUGGAGCUCUCACGGUU n.a.
 +
polyI/C poly (I/C)100–600 n.a.
 +/
n.a. not applicable.
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aRck/p54-dependent manner
The disappearance of GW bodies could be due either to
the degradation of its components or to their dispersal.
To address this issue, Dcp1 protein was analyzed in HeLa
cells 48h after siRNA transfection (Figure 6A). The
protein had the same abundance in cells transfected with
si-CPEB1.1, which strongly decreases the GW body
number, as in mock or si-Glo.1 transfected cells. This
indicated a redistribution of GW body components
toward the cytoplasm rather than a degradation.
In order to determine if the disassembly of GW bodies
by siRNA is reversible, we investigated the eﬀect of
arsenite after siRNA transfection. Indeed, beside its role
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4724 Nucleic Acids Research, 2007, Vol. 35, No. 14as an inducer of stress granules, arsenite has been shown
to promote the assembly of GW bodies (4). HeLa cells
were mock transfected or transfected with si-CPEB1.1,
si-Glo.2, si-p54 or si-GW182 for 48h and then treated or
not with arsenite for 30min. GW bodies and stress
granules were analyzed by immunoﬂuorescence using
anti-Dcp1 and anti-eIF3 antibodies, respectively.
Arsenite fully induced stress granule assembly in the ﬁve
samples (Figure 6B–E and data not shown). The number
of GW bodies strongly increased in mock transfected
cells, as previously described, with 100% of the cells
having numerous GW bodies (Figure 6B). The same
increase was observed in si-CPEB1.1, si-Glo.2 and
si-GW182 transfected cells (Figure 6C and D and data
not shown). By contrast, only a few cells recovered GW
bodies after si-p54 transfection (Figure 6D). Instead, the
Dcp1 protein relocalized in the newly assembled stress
granules (Figure 6E). The same results were obtained in
RPE cells. This indicated that, in most cases, arsenite is
suﬃcient to counteract the siRNA action on GW bodies.
Interestingly, at the dose used, arsenite is a strong
translation inhibitor (28). Therefore, the GW body
reinduction occurs in the absence of neo-synthesized
protein, conﬁrming that neither the CPEB1 nor the
GW182 protein are necessary for GW body assembly.
However, the p54 protein is truly required for the GW
body assembly, at least in response to arsenite.
DISCUSSION
GW bodies contain proteins involved in mRNA degrada-
tion, in RNA interference as well as in mRNA storage.
CPEB1 is known as a speciﬁc translation regulator acting
within a large multiprotein complex bound to the 3’
untranslated region of its target mRNAs. We have used
RNA interference to investigate its function in human
cells and found that the depletion of the CPEB1 protein is
accompanied by the disappearance of GW bodies. While
we had previously shown that the CPEB1 protein
accumulates in GW bodies, it seemed unlikely that the
depletion of a speciﬁc regulator present at low abundance
could induce GW body disassembly. We therefore tested a
larger set of siRNAs, including a siRNA targeting
Rck/p54, which is a CPEB1 partner also found in GW
bodies, siRNAs targeting mRNAs encoding proteins that
should not be involved in mRNA metabolism, such as
kinesins Kif15 and HSET, and tetraspanins CD9 and
CD81, which are transmembrane proteins expressed at the
cell surface, as well as irrelevant siRNAs designed against
mRNAs that are not expressed in the cells under study,
such as b-Globin and LT-a. Out of 15 siRNAs, ﬁve shared
this property of making GW bodies disappear: two
targeting CPEB1 and three targeting Rck/p54, CD81
and b-Globin, respectively. The eﬀect on GW bodies was
therefore not restricted to the siRNAs depleting proteins
obviously involved in mRNA metabolism.
The main parameter described so far to aﬀect GW body
number in mammals is the cell cycle, and the CPEB
protein is clearly involved in mitosis (16). In Xenopus
oocytes, CPEB-regulated genes include cyclins A and B,
Mos and Aurora-A kinases, Eg5 kinesin, histone H4, all of
which are involved in the resumption of meiosis (29).
In mammals, cyclin B1 translation is subject to a similar
regulation in the MCF7 cell line (30). The depletion of
CPEB1 in HeLa and RPE cells could therefore lead to
cyclin B1 misregulation and cell cycle abnormalities.
However, in spite of a drastic depletion of the CPEB1
protein, we did not observe any change in the cell cycle,
indicating either that CPEB1 is not responsible for cyclin
B1 regulation in these cells or that it can be replaced by a
functionally identical protein. Consequently, the disap-
pearance of the GW bodies was not related to a particular
accumulation in M or early G1 phase, which are the two
cell cycle phases where GW bodies are sparse.
It has also been reported that the number of GW bodies
decreases in 3T3 quiescent cells (16). RPE cells, which have
been immortalized by expression of the telomerase, are
highly sensitiveto contact inhibition andtheir proliferation
is down-regulated at conﬂuence, yet the number of GW
bodies increased in conﬂuent cells compared to that in
exponentiallygrowingcells(datanotshown).Similarly,the
number of GW bodies increased at conﬂuence in HeLa
cells (compare 44- and 72-h panels in Figure 1F). Thus,
conﬂuence and quiescence enhance GW bodies in these cell
lines, which is in agreement with the situation in yeast,
where P-bodies increase in number and brightness with cell
density (31). However, we observed no marked diﬀerence
of cell density 44h after transfection of the various siRNAs
(data not shown).
The fact that an siRNA designed against b-globin led to
the disappearance of GW bodies raised the possibility that
it was due to oﬀ-target silencing. First, as there is no
sequence similarity between the various siRNAs, they
would be expected to silence diﬀerent oﬀ-target genes, yet
lead to a common phenotype, which seems very unlikely.
Second, in the case of b-Globin and CPEB1 siRNAs, GW
bodies could be eﬃciently reinduced in 30min by arsenite,
despite the fact that arsenite fully inhibits protein
synthesis. This indicated that whatever proteins might be
involuntarily depleted, they were not required for the GW
body assembly. This strongly suggests that the disappear-
ance of the GW bodies in these cases is not due to the
depletion of a particular protein but rather to some
deregulation of GW body genesis.
One potential consequence of introducing double-
stranded RNA in mammalian cells is the activation of
the IFN pathway. Although short molecules are less
potent than long ones, siRNAs can nevertheless induce
part of the IFN response. This has been reported
following transfection of in vitro synthetized siRNAs
(27), plasmid-encoded shRNAs (32) and chemically
synthetized siRNAs (25,26). In the last case, some
siRNAs were found to be more potent than others,
depending on their sequence. Although these data were
obtained in cells from the immune system, it could have
provided an explanation for our observations. We tested
this hypothesis by measuring both IFN in the culture
medium of the transfected cells and OAS2 expression.
Indeed OAS2 was reported to be highly induced 48h after
siRNA transfection in RCC1 cells (27). Production of IFN
was undetectable and OAS2 mRNA was not induced after
Nucleic Acids Research, 2007, Vol. 35, No. 14 4725siRNA transfection, providing no evidence of IFN path-
way activation. Moreover, IFN addition to the culture
medium did not aﬀect the GW body number.
In the literature, the role of GW bodies in RNA
interference is still unclear. On the one hand, in one study,
GW182 depletion using RNA interference simultaneously
decreased the GW body number and the silencing by
miRNAs and siRNAs (8). In other studies, GW182
depletion led to a clear inhibition of miRNA-mediated
silencing but only to a slight inhibition of siRNA activity
(5,9). On the other hand, two studies reported that cells
lacking GW bodies could still perform eﬃcient siRNA-
mediated silencing. These cells were obtained either by
stably depleting Drosha protein using shRNA (10) or by
transiently silencing Lsm1 using siRNAs (11). The latter
study also reported that Rck/p54 protein is associated to
RISC but is not required for siRNA-mediated cleavage
activity. Our data are in full agreement with these two
studies, as no inhibition of siRNA activity was observed
following the disappearance of GW bodies. We therefore
conclude that RNA interference can take place outside of
the GW bodies.
A possible explanation for our observations could be
that, in certain cases, the large amount of transfected
siRNA molecules saturates RISC and progressively clears
it out of the GW bodies. Our functional data do not
support such a saturation eﬀect. First, the eﬀect on GW
body number is not related to the silencing eﬃciency of the
siRNA, which might be expected to be related to its aﬃnity
for RISC. Second, the silencing of Eg5 or Kif15 remained
intact after the disappearance of GW bodies, indicating no
saturation of the silencing machinery. Alternatively,
siRNAs could sequester, outside of the GW bodies,
RNA-binding proteins that are not involved in silencing
activity but that are required for GW body assembly. The
arsenite experiment argues against this possibility, as a
large number of GW bodies reappear in 30min while
protein synthesis is inhibited. Finally, a third hypothesis
would be that some siRNAs alter mRNA metabolism
through a mechanism still to be identiﬁed, leading to a
decrease of mRNAs directed to GW bodies. These would
be restored when translation is inhibited by arsenite.
Whatever be the explanation, it remains clear that the
disappearance of GW bodies following siRNA transfec-
tion does not obligatorily indicate that the targeted gene is
important for GW body assembly. RNA interference is
now a straightforward strategy to investigate protein
function in mammalian cells, and it has led to the
conclusion that many proteins of the GW bodies are
essential for their assembly: Ccr4, Rck/p54, Lsm1, eIF4ET
(18), GW182 (16), Ge1 (19) and Rap55 (20). How so many
proteins could all be required has not been much
discussed, and our results open up the possibility that
some of these proteins are not really essential for GW
body assembly. Our data indicate that GW182 is not the
GW body scaﬀold protein, as previously hypothesized
(16). It can be noted that Lsm1 depletion by a genetic
approach in yeast leads to more numerous P-bodies rather
than to their disappearance (2,33); it would be interesting
to use arsenite treatment to conﬁrm its importance for
GW body assembly. We found that depletion of Rck/p54
protein not only leads to the disappearance of GW bodies
but also prevents the induction of GW bodies by arsenite.
This protein is therefore strictly required for the assembly
of GW bodies, at least in response to arsenite. This is
reminiscent of the situation in yeast, where Dhh1 works
redundantly with Pat1, and the double Dhh1/Pat1
mutation prevents P-body formation in response to
glucose deprivation (34). Rck/p54 is an RNA-binding
protein of the DEAD box helicase family, with multiple
properties: it associates to Dcp1 and enhances decapping
in yeast (35), it associates to RISC and is required for
miRNA-mediated silencing in mammals (11) and it
belongs to a translation repressing complex along with
CPEB in Xenopus oocytes (36). It is an abundant protein
which could play a scaﬀolding or remodeling role in GW
bodies due to its helicase activity (37). Alternatively, it
could be part of the machinery which drives quiescent
mRNA to the GW bodies for storage and/or degradation.
Although GW bodies and stress granules are related
mRNP in terms of both structure and composition, Rck/
p54 silencing had absolutely no eﬀect on the stress granule
assembly. Interestingly, we found that Dcp1, which is
normally localized in the GW bodies independently of
arsenite treatment, relocated to stress granules in the
absence of Rck/p54. We have previously reported a
similar behavior when stress granules are induced by
CPEB1 expression (4). These two data suggest that, when
GW bodies are missing, stress granules can be a second
default localization of Dcp1 protein. Our data, obtained in
the same cellular context during arsenite treatment,
establish that, despite strong structural and functional
similarities between GW bodies and stress granules, their
assembly follows distinct pathways.
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